| 000 | 01448 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513045950.0 | ||
| 264 | 0 | _c19950323 | |
| 008 | 199503s 0 0 eng d | ||
| 022 | _a0001-6470 | ||
| 024 | 7 |
_a10.3109/17453679508994631 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKaukonen, J P | |
| 245 | 0 | 0 |
_aIntravenous cefuroxime prophylaxis. Tissue levels after one 3-gram dose in 40 cases of hip fracture. _h[electronic resource] |
| 260 |
_bActa orthopaedica Scandinavica _cFeb 1995 |
||
| 300 |
_a14-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aArthroplasty _xmethods |
| 650 | 0 | 4 |
_aBone and Bones _xchemistry |
| 650 | 0 | 4 |
_aCefuroxime _xpharmacokinetics |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aFascia _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFemoral Neck Fractures _xsurgery |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscles _xchemistry |
| 650 | 0 | 4 | _aPremedication |
| 650 | 0 | 4 |
_aSkin _xchemistry |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aTuomainen, P | |
| 700 | 1 | _aMäkijärvi, J | |
| 700 | 1 | _aMokka, R | |
| 700 | 1 | _aMännistö, P T | |
| 773 | 0 |
_tActa orthopaedica Scandinavica _gvol. 66 _gno. 1 _gp. 14-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/17453679508994631 _zAvailable from publisher's website |
| 999 |
_c7863096 _d7863096 |
||